CD274 and neoplasm: As the tumor cells expressed high PDL-1 and CTLA4 the syngeneic OSCC13 grafting model may be amenable for targeting immune checkpoints in particular in combination with radiotherapy as we have shown that OSCC13 cells and tumors are radiosensitive.